CMS strives to provide its beneficiaries with access to treatment with new technologies. In the outpatient setting, Medicare supports the provision of new technology procedures through reimbursement of these services under New Technology ACPs.
The Outpatient Prospective Payment System (OPPS) uses new technology APCs to pay for certain new services until CMS gathers sufficient claims data to enable it to assign the service to an appropriate clinical APC.
To be assigned to a New Technology APC, the service must meet certain criteria, including, but not limited to the following:
Once assigned, a service is paid under a New Technology APC until sufficient claims data have been collected (generally two to three years) to allow CMS to assign the procedure to a clinical APC group that is appropriate in clinical and resource terms.
CMS assigns new services to a New Technology APC. New Technology APCs are paid solely on the basis of cost and not the clinical characteristics of the service. The payment rate for each New Technology APC is based on a payment range called a cost band rather than on a relative payment weight. The cost band that the estimated costs for a procedure or service fall into determines the APC it is assigned to. Payment is made at the midpoint of the range for each cost band.
Example:
A new technology with an estimated cost of $510 falls into APC 1507, New Technology – Level 7. The cost band range for APC 1507 is $501 to $600. Procedures whose APCs fall into this cost band would be paid at an amount of $550.50.
For CY 2025 there are a total of 20 procedures or technologies being proposed for assignment to new technology APCs.
Proposed Technologies |
Administration of Subretinal Therapies Requiring Vitrectomy |
Biology Guided Radiation Therapy (BgRT) |
Blinded Interatrial Shunt Procedure |
Bronchoscopy With Transbronchial Ablation of Lesion(s) by Microwave Energy |
Cardiac Positron Emission Tomography (PET)/Computed Tomography (CT) Studies |
CardiAMP |
Atherosclerosis Imaging-Quantitative Computer Tomography (AI-QCT) |
Corvia Medical Interatrial Shunt Procedure |
DARI Motion Procedure |
Instillation of Anti-Neoplastic Pharmacologic/Biologic Agent Into Renal Pelvis |
LimFlow TADV Procedure CPT Code 0620T |
Liver Histotripsy Service |
LiverMultiScan Service |
Optellum Lung Cancer Prediction (LCP) |
Quantitative Magnetic Resonance (QMR) for Analysis of Tissue Composition |
Quantitative Magnetic Resonance Cholangiopancreatography (QMRCP) |
Scalp Cooling |
Supervised Visits for Esketamine Self-Administration |
Surfacer® Inside-Out® Access Catheter System |
Transcatheter Atrial Shunt System (TASS) |
In addition to New Technology APCs, CMS also supports beneficiaries’ access to new technology through the use of pass-through payments. While New Technology APCs reimburse providers for individual services, pass-through payments pay for specific drugs, biologics, and devices that providers use in the delivery of services. Pass-through payments are a method for reimbursing providers of new technologies for which an OPPS payment rate cannot be determined because the technology is so new that rate setting data is not available. Pass-through devices and drugs are required by statute to be paid separately under the OPPS.
Organizations that intend to use these technologies in 2025 are encouraged to visit the OPPS proposed or final rule to review the applicable information for each procedure or technology. Detailed information, including relevant CPT/HCPCS codes, can be found in section III.C.3.A-T Procedures Assigned to New Technology APCs for CY 2025 in the OPPS Proposed Rule and payment rates for the applicable APCs can be found in Addendum B.
To make sure you and your team are ready on January 1, 2025, to apply CPT and other significant payment changes, watch for the December 15 release of our upcoming course CY 2025 CPT and HOPPS Updates.
Since 1992, HIA has been the leading provider of compliance audits, coding support services and clinical documentation audit services for hospitals, ambulatory surgery centers, physician groups and other healthcare entities. HIA offers PRN support as well as total outsource support.
The information contained in this coding advice is valid at the time of posting. Viewers are encouraged to research subsequent official guidance in the areas associated with the topic as they can change rapidly.